Round Rock Advisors LLC Takes Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Round Rock Advisors LLC acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 523 shares of the medical equipment provider's stock, valued at approximately $259,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Brighton Jones LLC grew its holdings in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after purchasing an additional 731 shares during the last quarter. Bank Pictet & Cie Europe AG increased its position in shares of Intuitive Surgical by 0.5% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock worth $99,678,000 after acquiring an additional 883 shares during the period. Proficio Capital Partners LLC boosted its holdings in shares of Intuitive Surgical by 70.9% in the fourth quarter. Proficio Capital Partners LLC now owns 1,820 shares of the medical equipment provider's stock valued at $950,000 after purchasing an additional 755 shares during the period. King Luther Capital Management Corp increased its holdings in Intuitive Surgical by 4.3% during the 4th quarter. King Luther Capital Management Corp now owns 5,907 shares of the medical equipment provider's stock worth $3,083,000 after purchasing an additional 242 shares during the period. Finally, Moors & Cabot Inc. lifted its holdings in shares of Intuitive Surgical by 8.4% in the 4th quarter. Moors & Cabot Inc. now owns 1,256 shares of the medical equipment provider's stock worth $656,000 after buying an additional 97 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Barclays lowered their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. Evercore ISI upped their target price on Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a report on Tuesday. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday, June 5th. Robert W. Baird dropped their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Finally, Piper Sandler decreased their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $592.59.

Insider Activity

In other news, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the sale, the senior vice president directly owned 907 shares in the company, valued at $510,740.77. This trade represents a 19.23% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Gary Loeb sold 1,700 shares of the company's stock in a transaction dated Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the transaction, the executive vice president directly owned 2,245 shares of the company's stock, valued at $1,152,089.10. The trade was a 43.09% decrease in their position. The disclosure for this sale can be found here. Insiders sold 4,998 shares of company stock worth $2,611,577 over the last 90 days. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Down 2.7%

Shares of NASDAQ:ISRG traded down $13.99 during trading on Friday, hitting $512.06. The stock had a trading volume of 2,951,229 shares, compared to its average volume of 1,679,961. Intuitive Surgical, Inc. has a 12-month low of $413.82 and a 12-month high of $616.00. The stock has a 50-day simple moving average of $538.20 and a two-hundred day simple moving average of $536.86. The stock has a market capitalization of $183.53 billion, a price-to-earnings ratio of 75.08, a price-to-earnings-growth ratio of 5.58 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same period in the prior year, the firm earned $1.50 EPS. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.